Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nizar M. Tannir | Researchclopedia

Back to researchers

Nizar M. Tannir

The University of Texas MD Anderson Cancer Center ORCID

1,043

Works

31,342

Citations

83

h-index

330

i10-index

Research Topics

Renal cell carcinoma treatment Renal and related cancers Cancer Genomics and Diagnostics

Affiliations

University of North Carolina at Chapel Hill2011–2011

Dartmouth–Hitchcock Medical Center2009–2009

Fox Chase Cancer Center2009–2011

Houston Methodist2011–2012

Van Andel Institute2012–2012

Top Works

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer,Nizar M. Tannir,et al.

20184,544 citations

Cancer Immunotherapy and Biomarkers

Bladder and Urothelial Cancer Treatments

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Toni K. Choueiri,Bernard Escudier,et al.

20151,210 citations

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri,Bernard Escudier,et al.

2016934 citations

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Robert J. Motzer,Brian I. Rini,et al.

2019772 citations

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

Laurence Albigès,Nizar M. Tannir,et al.

2020517 citations

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

Ana M. Aparicio,Andrea Harzstark,et al.

2013460 citations

Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

Michael B. Atkins,Nizar M. Tannir

2018408 citations

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou,Xian-De Liu,et al.

2015387 citations

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

Nizar M. Tannir,Eric Jonasch,et al.

2015358 citations